Latest News and Events

GeoVax Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11
Recognizing the Support of the National Institutes of Health and the HIV Vaccine Trials Network&nb...
Continue Reading...
GeoVax Labs, Inc. Issues Letter to Shareholders
Updates on Zika, Ebola and HIV Vaccine Programs and Cancer Immunotherapy Initiative GeoVax Labs, ...
Continue Reading...
GeoVax Reports 2016 First Quarter Financial Results
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announce...
Continue Reading...